Stocks and Investing
Stocks and Investing
Mon, January 8, 2024
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
Josh Beck Maintained (ALKT) at Buy with Increased Target to $26 on, Jan 8th, 2024
Josh Beck of Keybanc, Maintained "Alkami Technology, Inc." (ALKT) at Buy with Increased Target from $21 to $26 on, Jan 8th, 2024.
Josh has made no other calls on ALKT in the last 4 months.
There are 5 other peers that have a rating on ALKT. Out of the 5 peers that are also analyzing ALKT, 2 agree with Josh's Rating of Hold. Following are those relevant analyst calls for the last 4 months
- Saket Kalia of "Barclays" Maintained at Hold with Increased Target to $26 on, Thursday, January 4th, 2024
- Charles Nabhan of "Stephens & Co." Downgraded from Buy to Hold and Held Target at $24 on, Thursday, December 7th, 2023
These are the ratings of the 3 analyists that currently disagree with Josh
- Mayank Tandon of "Needham" Maintained at Strong Buy with Increased Target to $30 on, Friday, January 5th, 2024
- Patrick Walravens of "JMP Securities" Maintained at Buy with Increased Target to $25 on, Friday, November 3rd, 2023
- Alexei Gogolev of "JP Morgan" Maintained at Buy with Increased Target to $21 on, Thursday, November 2nd, 2023
Contributing Sources